TI
AGTC

Trexquant Investment’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Trexquant Investment’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,000
Closed -$102K – 1100
2017
Q2 		$102K Buy
20,000
+611
+3% +$3.43K 0.03% 743
2017
Q1 		$134K Sell
19,389
-13,675
-41% -$107K 0.02% 1013
2016
Q4 		$309K Buy
+33,064
New +$298K 0.05% 632
2016
Q2 		– Sell
-41,882
Closed -$586K – 1180
2016
Q1 		$586K Buy
+41,882
New +$614K 0.07% 482

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trexquant Investment's AGTC Position: Q3 2017 in Review

Trexquant Investment sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2017, closing a stake of 20,000 shares — an estimated $102K sold.

Trexquant Investment first reported a position in AGTC in Q1 2016 and held it in 4 quarters. The position peaked at $586K in Q1 2016. 67 funds tracked by Wall St. Rank hold AGTC as of Q3 2017.

  • Trexquant Investment reported no remaining Applied Genetic Technologies Corporation position as of Q3 2017 after selling out during the quarter.
  • Trexquant Investment sold 20,000 Applied Genetic Technologies Corporation shares in Q3 2017, an estimated $102K.
  • Trexquant Investment first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 4 quarters.
  • Trexquant Investment's Applied Genetic Technologies Corporation position peaked at $586K in Q1 2016.
  • 67 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2017.

Based on Trexquant Investment's 13F filing for Q3 2017, filed 9 Nov 2017.